Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
Cancer Chemotherapy and Pharmacology|April 11, 2020
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation studyL H Mammatas, A S Zandvliet, M Rovithi, et al.
Annals of Neurology|August 1, 1995
The phenotypic spectrum related to the human epilepsy susceptibility gene "EJM1"T Sander, T Hildmann, D Janz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 27, 2020
A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumoursFlorence Atrafi, Herlinde Dumez, Ron H J Mathijssen, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 10, 2007
Pheochromocytoma mimicking an acute myocardial infarctionC W Menke-van der Houven van Oordt, Th B Twickler, F G M H van Asperdt, et al.
Radiobiologia, Radiotherapia|January 1, 1990
[A comparison of systemic radiotherapy, chemotherapy or local radiotherapy in the treatment of extensive small-cell bronchial carcinoma. Results of a randomized series]J Hüttner, H Grunau, K H Dallüge, et al.
American Journal of Medical Genetics|July 25, 1997
Allelic association of juvenile absence epilepsy with a GluR5 kainate receptor gene (GRIK1) polymorphismT Sander, T Hildmann, R Kretz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 12, 2024
Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lampU Reinhold, W G Philipp-Dormston, T Dirschka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2021
Biodistribution of 18F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER DegraderRamsha Iqbal, Maqsood Yaqub, Daniela E Oprea-Lager, et al.
European Journal of Neurology|May 29, 2009
Health-related quality of life measures and psychiatric comorbidity in patients with migraineM Mula, M Viana, R Jauch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2018
A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosisT Dirschka, S Ekanayake-Bohlig, R Dominicus, et al.
Pageof 29